Tumor-associated glycoprotein-72 serum levels complement carcinoembryonic antigen levels in monitoring patients with gastrointestinal carcinoma. A lingitudinal study
- 1 December 1991
- Vol. 68 (11) , 2443-2450
- https://doi.org/10.1002/1097-0142(19911201)68:11<2443::aid-cncr2820681120>3.0.co;2-2
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Ca 72-4 radioimmunoassay for the detection of the tag-72 carcinoma-associated antigen in serum of patientsJournal of Clinical Laboratory Analysis, 1989
- Monoclonal Antibody B72.3 Reactivity with Human EndometriumInternational Journal of Gynecological Pathology, 1987
- Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 72) on a novel pancarcinoma antigen (TAG‐72)International Journal of Cancer, 1986
- Differential reactivity of monoclonal antibodies with human colon adenocarcinomas and adenomasInternational Journal of Cancer, 1983
- Predictive value of plasma CEA levelsDiseases of the Colon & Rectum, 1982
- Carcinoembryonic antigen levels in asymptomatic adolescentsPublished by Elsevier ,1981
- The clinical significance of the pattern of elevated serum carcinoembryonic antigen (CEA) levels in recurrent colorectal cancerBritish Journal of Surgery, 1980
- Preoperative Carcinoembryonic Antigen Level as a Prognostic Indicator in Colorectal CancerNew England Journal of Medicine, 1978
- DETECTION OF RECURRENCE OF LARGE-BOWEL CARCINOMA BY RADIOIMMUNOASSAY OF CIRCULATING CARCINOEMBRYONIC ANTIGEN (C.E.A.)The Lancet, 1974
- The classification of cancer of the rectumThe Journal of Pathology and Bacteriology, 1932